Top Markets
Coin of the day
LifeMD, Inc. LifeMD, Inc.

LifeMD, Inc.

LFMDP
주식 순위 #6273
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects... LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
주가
$23.31
시가총액
$1.05B
변동 (1일)
-0.81%
변동 (1년)
-6.37%
국가
US
거래 LifeMD, Inc. (LFMDP)

카테고리

LifeMD, Inc. (LFMDP)의 P/E 비율
March 2026 기준 P/E 비율 TTM: 12.04
LifeMD, Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/E (TTM) 비율은 12.04입니다. 2023년 말 기준 P/E 비율은 -13.65였습니다.
LifeMD, Inc.의 P/E 비율 기록 (2011 ~ 2026)
매년 말 P/E 비율
연도 P/E 비율 변화
2026 (TTM) 12.04 -211.44%
2024 -10.80 -20.86%
2023 -13.65 922.40%
2022 -1.33 -21.69%
2021 -1.70 10.66%
2020 -1.54 -8.50%
2019 -1.68 -66.24%
2018 -4.99 -59.79%
2017 -12.40 49.85%
2016 -8.27 -86.13%
2015 -59.64 804.23%
2014 -6.60 -76.83%
2013 -28.47 188.12%
2012 -9.88 -33.88%
2011 -14.95 0.00%
유사 기업 또는 경쟁사의 P/E 비율
회사 P/E 비율 P/E 비율 차이 국가
30.93 156.99%
HK
31.77 163.96%
BR
17.49 45.30%
JP
18.15 50.80%
CN
14.54 20.82%
JP
P/E 비율 읽는 방법

P/E 비율은 회사의 주가와 주당순이익 간의 관계를 측정합니다.
낮지만 양수인 P/E는 현재 가치 대비 높은 수익을 내고 있는 저평가된 기업을 의미합니다. 높은 음수(0에 가까운) P/E는 큰 손실을 나타냅니다.

P/E가 30을 초과하거나 음수인 기업은 일반적으로 '성장주'로 간주되며, 투자자들은 향후 수익성 개선을 기대합니다.

양의 P/E가 10 미만인 기업은 일반적으로 '가치주'로 간주되며, 이미 매우 수익성이 높고 향후 큰 성장은 기대되지 않습니다.